Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	764.32	751.56	706.92	822.92	723.79	568.2
Other Revenue	0.85	0.85	1.12	2.03	1.44	-
Revenue	765.17	752.41	708.04	824.95	725.23	568.2
Revenue Growth (YoY)	8.85%	6.27%	-14.17%	13.75%	27.64%	8.84%
Cost of Revenue	416.54	413.39	392.1	424.85	530.24	427.47
Gross Profit	348.63	339.02	315.94	400.1	194.99	140.73
Selling, General & Admin	173.83	168.47	138.31	109.2	5.44	5.38
Other Operating Expenses	43.38	42.33	32	41.22	34.22	30.23
Operating Expenses	263.21	253.94	207.76	186.83	76.79	69.67
Operating Income	85.42	85.08	108.19	213.26	118.2	71.07
Interest Expense	-4.75	-5.78	-6.08	-6.85	-6.36	-5.15
Interest & Investment Income	9.39	10.25	9.76	2.74	0.63	1.15
EBT Excluding Unusual Items	90.05	89.55	111.87	209.15	112.48	67.06
Impairment of Goodwill	-2.6	-2.6	-	-5.87	-3.78	-3.5
Asset Writedown	-0	-0	7.4	-12.03	0.41	-4.5
Other Unusual Items	0.02	0.02	0.17	0.08	6.47	25.38
Pretax Income	87.46	86.96	119.44	191.34	115.58	84.44
Income Tax Expense	23.65	24.68	28.35	47.94	31.87	19.77
Earnings From Continuing Operations	63.81	62.28	91.09	143.4	83.72	64.67
Minority Interest in Earnings	-0.11	-0.04	-0.94	-0.19	0.46	1.22
Net Income	63.71	62.24	90.15	143.21	84.17	65.89
Net Income to Common	63.71	62.24	90.15	143.21	84.17	65.89
Net Income Growth	4.54%	-30.96%	-37.05%	70.15%	27.74%	9.32%
Shares Outstanding (Basic)	1,856	1,857	1,859	1,857	1,868	1,839
Shares Outstanding (Diluted)	1,856	1,861	1,869	1,866	1,876	1,840
Shares Change (YoY)	-1.15%	-0.41%	0.12%	-0.54%	1.96%	1.35%
EPS (Basic)	0.03	0.03	0.05	0.08	0.05	0.04
EPS (Diluted)	0.03	0.03	0.05	0.08	0.04	0.04
EPS Growth	5.97%	-30.70%	-37.16%	70.82%	25.42%	7.83%
Free Cash Flow	97.85	66.98	168.79	171.21	110.17	74.27
Free Cash Flow Per Share	0.05	0.04	0.09	0.09	0.06	0.04
Dividend Per Share	0.025	0.025	0.024	0.038	0.018	0.025
Dividend Growth	4.17%	4.17%	-36.84%	111.11%	-28.00%	-
Gross Margin	45.56%	45.06%	44.62%	48.50%	26.89%	24.77%
Operating Margin	11.16%	11.31%	15.28%	25.85%	16.30%	12.51%
Profit Margin	8.33%	8.27%	12.73%	17.36%	11.61%	11.60%
Free Cash Flow Margin	12.79%	8.90%	23.84%	20.75%	15.19%	13.07%
EBITDA	116.29	115.09	132.9	239.72	143.3	94.23
EBITDA Margin	15.20%	15.30%	18.77%	29.06%	19.76%	16.58%
D&A For EBITDA	30.87	30.01	24.71	26.46	25.1	23.17
EBIT	85.42	85.08	108.19	213.26	118.2	71.07
EBIT Margin	11.16%	11.31%	15.28%	25.85%	16.30%	12.51%
Effective Tax Rate	27.04%	28.38%	23.73%	25.05%	27.57%	23.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.